Eli Lilly
$200.549876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$200.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.46 (-0.72%) Today
$0.00 (0.00%) As of 9:45 PM UTC after-hours
Why Robinhood?
You can buy or sell Eli Lilly and other stocks, options, and ETFs commission-free!
About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN. The listed name for LLY is Eli Lilly & Co.
CEO
David A. Ricks
Employees
35,000
Headquarters
Indianapolis, Indiana
Founded
1876
Market Cap
192.91B
Price-Earnings Ratio
30.08
Dividend Yield
1.50
Average Volume
3.53M
High Today
$204.74
Low Today
$198.62
Open Price
$203.73
Volume
4.26M
52 Week High
$218.00
52 Week Low
$117.06
LLY News
MarketWatch24h
Eli Lilly & Co. stock outperforms market despite losses on the day
Shares of Eli Lilly & Co. LLY, -1.05% slipped 1.05% to $202.00 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with t
Analyst Ratings
60%
of 20 ratings
Buy
60%
Hold
35%
Sell
5%
LLY Earnings
$0.00
$0.92
$1.83
$2.75
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Apr 27, Pre-Market